SAA1 and acute myeloid leukemia: To confirm the increased expression of SAA1 proteins in BM plasma from AML patients, we performed an ELISA with a larger number of samples, including samples from patients with different AML subtypes (n = 22) and healthy donors (n = 16) (Table 1 and Table 2—ELISA cohort).